Published in TB and Outbreaks Week, September 16th, 2003
"Much is known about specific antibodies and their titers in patients with tuberculosis," researchers in the Netherlands explained. "However, little is known about the avidity of these antibodies or whether changes in avidity occur during the progression of the disease or during treatment."
L.M.P. Ariasbouda and colleagues at the Royal Tropical Institute in Amsterdam conducted a study "to determine the avidity of antibodies to Mycobacterium tuberculosis in patients with pulmonary tuberculosis, to explore the value of avidity determination for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.